AVANT GUARD Clinical Trial to Evaluate FARAPULSE™ Pulsed Field Ablation System | Reports Boston Scientific as First-Line Treatment for Persistent Atrial Fibrillation
The AVANT GUARD clinical trial will evaluate the safety and [...]
First Patient Dosed in Clinical Trial of YOLT-201 for the Treatment of Hereditary ATTR-CM
YOLT-201 Injection utilizes several lipid components including ionizable lipids as [...]
Menarini Group Presented Initial Safety and Efficacy Data from Phase 1b/2 ELEVATE and ELECTRA Combination Studies of ORSERDU® (Elacestrant) in Patients with ER+, HER2- Metastatic Breast Cancer (mBC) at the 2023 San Antonio Breast Cancer Symposium
“It is encouraging to see positive initial safety results in [...]
AngioDynamics Completes Patient Enrollment in APEX-AV Study Assessing AlphaVac F1885 System in Treatment of Pulmonary Embolism
“The completion of the APEX-AV Study represents an important milestone [...]
Stoke Therapeutics Presents Data From Multiple Studies of Children and Adolescents With Dravet Syndrome at the American Epilepsy Society 2023 Annual Meeting
Data from clinical studies of STK-001 demonstrated clinical benefit for [...]
Clinical Validation Data Published in CHEST Demonstrate that Veracyte’s Percepta Nasal Swab Test Improves Lung Cancer Risk Assessment for Patients with Lung Nodules
The findings suggest that the novel, non-invasive genomic test can [...]
Outstanding 12-month First-in-human Data from Xeltis’ aXess Hemodialysis Vascular Conduit Trial Presented at VEITHsymposium 2023
Xeltis, a leading developer of transformative implants that enable the [...]
Humacyte Announces Two Presentations at the VEITHsymposium of Positive Clinical Results of the Human Acellular Vessel™ (HAV™) in the Treatment of Vascular Trauma
The two presentations were made at the VEITHsymposium, a major [...]
Alimentiv, AcelaBio, and PharmaNest Unite To Revolutionize Precision Medicine and AI Digital Pathology For NASH/MASH Clinical Trials
This collaboration will enable clinical trial sponsors to quantify the [...]
Annexin Pharmaceuticals Reports First Patient Treated in the Second Dose Group in Annexin’s RVO Study
“During the autumn, we have visited several of our active [...]